Yes! Why would anybody sell just before a published study is about to come out very soon - first week of August according to Erbb; and the quarterly report due out on August 15th according to uksausage (when sales are increasing), and we may have a new category in September - according to the rumor mill, as well as already re-filed 510k with FDA...Why would this be a good time to sell? It all sounds strange to me how this private interview supposedly ended with AW. Also, I need to hear straight from AW myself about share structure - not just one person's interpretation. SPENDING needs to be curtailed for a while if any more expensive studies have to be done and AW needs to allow sales to increase as well as putting reasonable pressure on FDA to get them to finally finish up what THEY started - coming up on about a year and a half ago!
Market Data 
Markets 
AI
